Categories
Market Updates

Biosimilar Market Size, Share, Growth Opportunities, Trends Analysis & Industry Forecast Report, 2020-2027 – X herald

Biosimilar Market:

The GMI Research’s latest analysis reveals that the Biosimilar Market is slated to register a higher CAGR over the coming years. This is mainly attributed to the growing penetration of chronic diseases globally driven by the rising fast-food consumption in people, the increasing number of diagnoses of particular pathologies, origin of new biologic products, and the rising inactive lifestyle.

Request for a FREE Sample Report on Biosimilar Market

Biosimilar Market’s leading Manufacturers:

  • Pfizer Inc.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • Biocon
  • Celltrion Healthcare Co., Ltd.
  • Samsung Biologics
  • Amgen Inc.
  • Reddy’s Laboratories Ltd.
  • Viatris Inc.

Biosimilar Market Dynamics (including market size, share, trends, growth, forecast, and industry analysis)

Key Drivers

The growing penetration of chronic diseases globally driven by the rising fast-food consumption in people and the increasing inactive lifestyle are the key drivers responsible for the growth of the biosimilar market size. As per the biosimilar market report, the low cost of biosimilars owing to decreased clinical trials has surged access of the patients to the treatment. This will augment the growth of the biosimilar market. The increasing number of diagnosis of particular pathologies and the introduction of new biologic products will further fuel the growth of the biosimilar market share in terms of revenue in the coming years. According to the biosimilar market forecast, the rise in the R&D activities in several regions, including Asia-Pacific, the growth in the geriatric population, and the increasing emphasis on reducing the healthcare cost across emerging economies are certain factors that are expected to drive the growth of the market. On the other hand, the factors hampering the growth of the biosimilar market include limited definitive standards for approval and the strong presence of several complexities in the manufacturing process.

Indication Segment Drivers

Based on the indication, oncology indication is predicted to grow at a faster CAGR due to the increasing number of cancer cases, including lung, blood, and liver cancer, and the growing number of products introduces the oncology products. Furthermore, an upsurge in the investments by several pharmaceuticals enterprises in the research and development activities for the development of new oncology biosimilars is further stimulating the growth of the market.

Product Segment Drivers

Based on the product, the monoclonal bodies is expected to rise at a faster CAGR due to the growth in the number of people struggling with cancer, diabetes, and autoimmune diseases. Additionally, several benefits provided by monoclonal bodies, such as the capability to produce antibodies when needed, improved sensitivity, and high scalability & reproducibility are the drivers bolstering the growth of the market.

To Know More About Biosimilar Market

Biosimilar Market Segmentation:

Segmentation by Product:
  • Insulin
  • Monoclonal Antibodies
  • Erythropoietin
  • Granulocyte Colony-Stimulating Factor
  • Etanercept
  • Recombinant Human Growth Hormone
  • Teriparatide
  • Follitropin
  • Interferons
  • Enoxaparin Sodium
  • Calcitonin
  • Glucagon
Segmentation by Type of Manufacturing:
  • Contract Manufacturing
  • In-House Manufacturing
Segmentation by Indication:
  • Chronic Diseases
  • Oncology
  • Blood Disorders
  • Autoimmune Diseases
  • Infectious Diseases
  • Growth Hormone Deficiency
  • Other Indications

Segmentation by Region:

  • North America
    • United States of America
    • Canada

 

  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of APAC
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Rest of Europe
  • RoW
    • Brazil
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of the world (remaining countries of the LAMEA region)

About GMI Research

GMI Research is one of the leading market research and consulting company that offers consulting services, syndicated research reports, and customized market research reports. We help our client to make informed business decisions and provide market intelligence studies related to the various industries such as automotive, energy, healthcare, chemicals, technology, and other sectors. Our research teams include seasoned analysts and researchers have hands-on experience in every regions, including Asia-pacific, Europe, North America, and the Rest of the World. Our market research report provides in-depth analysis, which contains refined forecasts, a bird’s eye view of the competitive landscape, factors impacting the market growth, and several other market insights to aid companies in making strategic decisions. Featured in the ‘Top 20 Most Promising Market Research Consultants’ list of Silicon India Magazine in 2018, we at GMI Research are always looking forward to help our clients to stay ahead of the curve.

Media Contact
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Email: enquiry@gmiresearch.com
Phone: Europe – +353 1 442 8820; US – +1 860 881 2270
Address: Dublin, Ireland
Website: www.gmiresearch.com

Press Release Distributed by Xherald

Leave a Reply

Your email address will not be published. Required fields are marked *